AB
AXSM icon

Amalgamated Bank’s Axsome Therapeutics AXSM Stock Holding History

Amalgamated Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$765K Buy
3,127
+1,838
+143% +$399K 0.01% 1219
2026
Q1 		$218K Hold
1,289
– – ﹤0.01% 1539
2025
Q4 		$235K Buy
1,289
+20
+2% +$2.79K ﹤0.01% 1525
2025
Q3 		$154K Hold
1,269
– – ﹤0.01% 1632
2025
Q2 		$132K Hold
1,269
– – ﹤0.01% 1652
2025
Q1 		$148K Buy
1,269
+17
+1% +$1.94K ﹤0.01% 1599
2024
Q4 		$106K Hold
1,252
– – ﹤0.01% 1691
2024
Q3 		$113K Hold
1,252
– – ﹤0.01% 1688
2024
Q2 		$101K Buy
1,252
+36
+3% +$2.67K ﹤0.01% 1707
2024
Q1 		$97K Sell
1,216
-3,874
-76% -$325K ﹤0.01% 1729
2023
Q4 		$405K Sell
5,090
-139
-3% -$9.29K ﹤0.01% 1520
2023
Q3 		$365K Buy
5,229
+257
+5% +$19.2K ﹤0.01% 1556
2023
Q2 		$357K Buy
4,972
+443
+10% +$32.7K ﹤0.01% 1590
2023
Q1 		$279K Sell
4,529
-750
-14% -$49.3K ﹤0.01% 1671
2022
Q4 		$407K Buy
5,279
+467
+10% +$27.9K ﹤0.01% 1559
2022
Q3 		$215K Buy
4,812
+261
+6% +$13K ﹤0.01% 1817
2022
Q2 		$174K Buy
4,551
+26
+0.6% +$822 ﹤0.01% 1934
2022
Q1 		$187K Buy
+4,525
New +$140K ﹤0.01% 1967
2021
Q3 		– Sell
-5,248
Closed -$354K – 2165
2021
Q2 		$354K Buy
5,248
+1,308
+33% +$78.5K ﹤0.01% 1805
2021
Q1 		$223K Sell
3,940
-392
-9% -$27.6K 0.01% 1430
2020
Q4 		$353K Buy
4,332
+22
+0.5% +$1.65K 0.01% 1143
2020
Q3 		$307K Sell
4,310
-123
-3% -$9.58K 0.01% 1100
2020
Q2 		$365K Sell
4,433
-202
-4% -$15.5K 0.02% 1000
2020
Q1 		$273K Buy
4,635
+47
+1% +$3.83K 0.01% 1194
2019
Q4 		$474K Buy
+4,588
New +$185K 0.01% 1145

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Amalgamated Bank's AXSM Position: Q2 2026 in Review

Amalgamated Bank increased its Axsome Therapeutics (AXSM) stake by 143% in Q2 2026, buying an estimated $399K and bringing the position to 3,127 shares worth $765K. The position accounts for 0.01% of the portfolio, ranked #1219.

Amalgamated Bank first reported a position in AXSM in Q4 2019 and has held it in 25 quarters since. 207 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Amalgamated Bank held 3,127 shares of Axsome Therapeutics worth $765K as of Q2 2026.
  • Amalgamated Bank bought 1,838 Axsome Therapeutics shares in Q2 2026, an estimated $399K.
  • Axsome Therapeutics made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1219 holding.
  • Amalgamated Bank first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 25 quarters since.
  • 207 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.